Monday, Feb 3, 2025 · SEC filings

What the smart money revealed on Feb 3

Real insider buys28insiders · $70.7M
Real insider sales51insiders · $324M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

804 insider filings came in. We hid 55 planned (10b5-1) sellers and 643 people whose filings were routine, like grants and tax withholding.

group

4 insiders at Infinity Natural Resources (INR) bought $1.6M of stock

Roles: Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Feb 3
$1.6M
group

3 insiders at Corient Registered Alternatives Fund bought $400K of stock

Roles: President, Treasurer, Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Feb 3
$400K
trending_up

89bio (ETNB) Director Peter Kolchinsky bought $50M

5.71M shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 6 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 2 of 6 beat Traded Jan 30
$50M
trending_up

Metsera (MTSR) Director Paul Berns bought $14.2M

789,998 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Feb 3
$14.2M
trending_up

Ashland (ASH) Chair of the Board and CEO Guillermo Novo bought $2.01M

31,294 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 31
$2.01M
trending_up

Immunome (IMNM) President and CEO Clay Siegall bought $1.16M

150,000 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 6 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 2 of 6 beat Traded Jan 31
$1.16M
trending_down

Axis Capital (AXS) Director Charles Davis sold $200M

Not marked as a planned 10b5-1 sale. Sold 33% of the shares they held directly. Still holds 4.54M shares.

Real sale Form 4 Sold 33% of stake Traded Feb 3
$200M
trending_down

Stryker (SYK) Director Ronda Stryker sold $79M

Not marked as a planned 10b5-1 sale. Sold 5% of the shares they held directly. Still holds 3.64M shares.

Real sale Form 4 Traded Jan 31
$79M
trending_down

3M (MMM) EVP and Chief Public Affairs Off Victoria Clarke sold $270K

Not marked as a planned 10b5-1 sale. Sold 90% of the shares they held directly. Still holds 194 shares.

Real sale Form 4 Sold 90% of stake Traded Jan 31
$270K
Show 17 more real buys
Show 48 more real sales
SMG Scotts Miracle-Gro · Chairman and CEO James Hagedorn · Traded Jan 30
$10.2M
PNFP Pinnacle Financial Partners · Director David Ingram · Traded Jan 30–31
$7.33M
CLS Celestica · CEO Robert Mionis · Traded Jan 31
$6.71M
ROP Roper Technologies · EVP Jason Conley · Traded Jan 31
$1.73M
CFR Cullen/Frost Bankers · President of CFR Paul Bracher · Traded Jan 31
$1.6M
GLW Corning · President and COO Eric Musser · Traded Jan 31
$1.56M
DRI Darden Restaurants · SVP Douglas Milanes · Traded Jan 30
$1.55M
CLS Celestica · President Jason Phillips · Traded Jan 31
$1.38M
CLS Celestica · President Todd Cooper · Traded Jan 31
$1.22M
CLS Celestica · CFO Mandeep Chawla · Traded Jan 31
$1.21M
CLS Celestica · Chief Operations Officer Yann Etienvre · Traded Jan 31
$1.17M
BPOP Popular · Executive Vice President Luis Cestero · Traded Jan 31
$1.03M
SNX TD SYNNEX · CEO Patrick Zammit · Traded Jan 30
$976K
NE Noble · EVP and CFO Richard Barker · Traded Jan 30
$739K
RJF Raymond James Financial · EVP Jonathan Santelli · Traded Jan 31
$700K
ROP Roper Technologies · Executive VP John Stipancich · Traded Jan 31
$578K
JBL Jabil · Director Christopher Holland · Traded Jan 31
$552K
WSBF Waterstone Financial · Director Kristine Rappe · Traded Jan 30–31
$467K
IONS Ionis Pharmaceuticals · CEO Brett Monia · Traded Jan 31
$430K
CLS Celestica · Chief Human Resources Officer Leila Wong · Traded Jan 31
$403K
WSBF Waterstone Financial · Director Stephen Schmidt · Traded Jan 30–31
$377K
EAT Brinker International · Director Frances Allen · Traded Jan 30–31
$367K
BOKF BOK Financial · Director Steven Bangert · Traded Jan 30
$336K
SMG Scotts Miracle-Gro · EVP and Chief of Staff Christopher Hagedorn · Traded Jan 30
$255K
SSII SS Innovations International · Chairman and CEO Sudhir Srivastava · Traded Jan 31
$250K
CLS Celestica · Chief Strategy Officer Alok Agrawal · Traded Jan 31
$225K
ROP Roper Technologies · Director Richard Wallman · Traded Jan 31
$202K
FMNB Farmers National Banc · Director Ralph Macali · Traded Jan 31
$200K
BOH Bank of Hawaii · Vice Chair and CAO Patrick McGuirk · Traded Jan 31
$150K
AGNC AGNC Investment · EVP Bernice Bell · Traded Jan 30
$131K
WRLD World Acceptance · SVP Alice Caulder · Traded Jan 31
$83.9K
UNTY Unity Bancorp · Director Mark Brody · Traded Jan 31
$77.3K
CHCO City Holding · EVP and CFO David Bumgarner · Traded Jan 30
$66.7K
IONS Ionis Pharmaceuticals · EVP Elizabeth Hougen · Traded Jan 31
$49.4K
IONS Ionis Pharmaceuticals · EVP Eugene Schneider · Traded Jan 31
$47.8K
IONS Ionis Pharmaceuticals · EVP CLO and General Counsel Patrick O'neil · Traded Jan 31
$45.7K
IONS Ionis Pharmaceuticals · EVP Richard Geary · Traded Jan 31
$45.6K
IONS Ionis Pharmaceuticals · EVP Research Eric Swayze · Traded Jan 31
$44.2K
IONS Ionis Pharmaceuticals · EVP C. Frank Bennett · Traded Jan 31
$43.1K
EQBK Equity Bancshares · CEO Richard Sems · Traded Jan 31
$26.3K
EQBK Equity Bancshares · COO and EVP Julie Huber · Traded Jan 30–31
$26.2K
EQBK Equity Bancshares · General Counsel Brett Reber · Traded Jan 30–31
$25.6K
EQBK Equity Bancshares · Chief Credit Officer Krzysztof Slupkowski · Traded Jan 30–31
$7.61K
EQBK Equity Bancshares · Chief Information Officer David Pass · Traded Jan 31
$6.63K
BWFG Bankwell Financial Group · EVP and Chief Risk Officer Steven Brunner · Traded Jan 31
$6.21K
EQBK Equity Bancshares · Chief Human Resources Officer Ann Knutson · Traded Jan 31
$6.02K
CBUS Cibus · Director Gerhard Prante · Traded Jan 31
$2.93K
BBNX Beta Bionics · Chief Product Officer Mike Mensinger · Traded Jan 31
$221

13F season

Holdings as of Dec 31, 2024 are due Feb 14

81 funds have filed so far. 58 filed for the quarter before.

Biggest real insider buys, Jan 28–Feb 3

Open-market buys by officers and directors, filed in the 7 days up to Feb 3.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist